Amy Goldstein

2.6k total citations · 1 hit paper
29 papers, 1.1k citations indexed

About

Amy Goldstein is a scholar working on Molecular Biology, Clinical Biochemistry and Genetics. According to data from OpenAlex, Amy Goldstein has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Clinical Biochemistry and 5 papers in Genetics. Recurrent topics in Amy Goldstein's work include Mitochondrial Function and Pathology (19 papers), Metabolism and Genetic Disorders (18 papers) and Genomics and Rare Diseases (5 papers). Amy Goldstein is often cited by papers focused on Mitochondrial Function and Pathology (19 papers), Metabolism and Genetic Disorders (18 papers) and Genomics and Rare Diseases (5 papers). Amy Goldstein collaborates with scholars based in United States, Canada and Belgium. Amy Goldstein's co-authors include Amel Karaa, Richard Haas, Bruce H. Cohen, Jerry Vockley, Mary Kay Koenig, Sumit Parikh, Fernando Scaglia, Lynne A. Wolfe, Mark A. Tarnopolsky and Russell P. Saneto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Human Molecular Genetics.

In The Last Decade

Amy Goldstein

26 papers receiving 1.1k citations

Hit Papers

Diagnosis and management of mitochondrial disease: a cons... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Goldstein United States 15 779 532 144 144 89 29 1.1k
Concetta Meli Italy 15 460 0.6× 573 1.1× 181 1.3× 140 1.0× 106 1.2× 45 874
François Feillet France 15 248 0.3× 251 0.5× 212 1.5× 152 1.1× 98 1.1× 45 685
Ann Bowron United Kingdom 13 424 0.5× 303 0.6× 100 0.7× 79 0.5× 107 1.2× 29 997
Cheryl Garganta United States 15 249 0.3× 212 0.4× 158 1.1× 90 0.6× 62 0.7× 28 745
Lance H. Rodan United States 17 285 0.4× 144 0.3× 64 0.4× 118 0.8× 79 0.9× 48 763
Yoshinobu Ohtani Japan 12 339 0.4× 275 0.5× 94 0.7× 111 0.8× 291 3.3× 25 726
Juan Darío Ortigoza‐Escobar Spain 14 243 0.3× 199 0.4× 63 0.4× 60 0.4× 109 1.2× 49 712
Areeg El‐Gharbawy United States 17 299 0.4× 248 0.5× 341 2.4× 249 1.7× 43 0.5× 31 1.1k
Claire Douillard France 18 412 0.5× 140 0.3× 212 1.5× 202 1.4× 74 0.8× 59 968
Parvaneh Karimzadeh Iran 14 141 0.2× 141 0.3× 230 1.6× 48 0.3× 122 1.4× 95 579

Countries citing papers authored by Amy Goldstein

Since Specialization
Citations

This map shows the geographic impact of Amy Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Goldstein more than expected).

Fields of papers citing papers by Amy Goldstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Goldstein. The network helps show where Amy Goldstein may publish in the future.

Co-authorship network of co-authors of Amy Goldstein

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Goldstein. A scholar is included among the top collaborators of Amy Goldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Goldstein. Amy Goldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ganetzky, Rebecca, et al.. (2025). Improving acute care for Primary Mitochondrial Disease: Development of a publicly available clinical care pathway. Molecular Genetics and Metabolism. 144(4). 109058–109058.
3.
Kandemirli, Sedat Giray, et al.. (2025). Overview of neuroimaging in primary mitochondrial disorders. Pediatric Radiology. 55(4). 765–791.
4.
Karaa, Amel, Michelangelo Mancuso, Bruce M. Cohen, et al.. (2022). Genetic subgroup learnings from MMPOWER-3 trial: Elamipretide improved six-minute walk test in individuals with mtDNA replisome disorders. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1863. 148868–148868. 1 indexed citations
5.
Toro, Camilo, Roderick Hori, May Christine V. Malicdan, et al.. (2017). A recurrent de novo missense mutation in UBTF causes developmental neuroregression. Human Molecular Genetics. 27(4). 691–705. 29 indexed citations
6.
Obeid, Rawad, et al.. (2017). A Newborn With Hyperlactatemia and Epileptic Encephalopathy. Seminars in Pediatric Neurology. 26. 104–107. 2 indexed citations
7.
Parikh, Sumit, Amel Karaa, Amy Goldstein, et al.. (2016). Solid organ transplantation in primary mitochondrial disease: Proceed with caution. Molecular Genetics and Metabolism. 118(3). 178–184. 46 indexed citations
8.
Ghaloul‐Gonzalez, Lina, Amy Goldstein, Catherine Walsh Vockley, et al.. (2016). Mitochondrial respiratory chain disorders in the Old Order Amish population. Molecular Genetics and Metabolism. 118(4). 296–303. 3 indexed citations
9.
Koenig, Mary Kay, Lisa Emrick, Amel Karaa, et al.. (2016). Recommendations for the Management of Strokelike Episodes in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Strokelike Episodes. JAMA Neurology. 73(5). 591–591. 72 indexed citations
10.
Zuccoli, Giulio, et al.. (2015). Bilateral symmetrical basal ganglia and thalamic lesions in children: an update (2015). Neuroradiology. 57(10). 973–989. 20 indexed citations
11.
Goldstein, Amy, Riyad El‐Khoury, Malgorzata Rak, et al.. (2015). ANT2-defective fibroblasts exhibit normal mitochondrial bioenergetics. SHILAP Revista de lepidopterología. 3. 43–46. 4 indexed citations
12.
Hu, Jie, Malini Sathanoori, Meron Azage, et al.. (2015). A novel maternally inherited 8q24.3 and a rare paternally inherited 14q23.3 CNVs in a family with neurodevelopmental disorders. American Journal of Medical Genetics Part A. 167(8). 1921–1926. 16 indexed citations
13.
El‐Gharbawy, Areeg, Jessica Sebastian, Lina Ghaloul‐Gonzalez, et al.. (2015). LARS mutations in non-Irish travelers: An under-recognized multi-system disorder characterized by infantile hepatopathy during physiological stress. Mitochondrion. 24. S40–S41. 3 indexed citations
14.
Parikh, Sumit, Amy Goldstein, Mary Kay Koenig, et al.. (2014). Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genetics in Medicine. 17(9). 689–701. 372 indexed citations breakdown →
15.
Kazmerski, Traci M., Ingrid Libman, Amy Goldstein, et al.. (2013). Infantile Hypophosphatasia Secondary to a Novel Compound Heterozygous Mutation Presenting with Pyridoxine-Responsive Seizures. JIMD Reports. 11. 17–24. 29 indexed citations
16.
Goldstein, Amy & Lynne A. Wolfe. (2013). The Elusive Magic Pill: Finding Effective Therapies for Mitochondrial Disorders. Neurotherapeutics. 10(2). 320–328. 11 indexed citations
17.
Goldstein, Amy, et al.. (2013). Mitochondrial Disease in Childhood: Nuclear Encoded. Neurotherapeutics. 10(2). 212–226. 28 indexed citations
18.
Vandewalle, Joke, Marijke Bauters, Hilde Van Esch, et al.. (2013). The mitochondrial solute carrier SLC25A5 at Xq24 is a novel candidate gene for non-syndromic intellectual disability. Human Genetics. 132(10). 1177–1185. 22 indexed citations
19.
Goldstein, Amy, et al.. (2012). Update on Nuclear Mitochondrial Genes and Neurologic Disorders. Seminars in Pediatric Neurology. 19(4). 181–193. 4 indexed citations
20.
Abuelo, Dianne, et al.. (1991). Anxiety in women with low maternal serum alpha‐fetoprotein screening results. Prenatal Diagnosis. 11(6). 381–385. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026